Spin-offs/Vivani Medical, Inc. → Cortigent, Inc.

Cortigent, Inc.CRGT

Spin-off from Vivani Medical, Inc. (VANI) · Form 10 filed May 2025 · Nasdaq

Announced

—

Form 10 filed

May 28, 2025

Record date

—

Expected distribution

—

Ratio

TBD

Debt loaded

—

Cash to parent

—

Latest filing

Sep 19, 2025

ratio left blank in the latest amendment

Documents

Form 10 Information statement New company filings Parent filings

Both companies today

The new company

Cortigent, Inc.CRGT

Market cap

—

Moat

Pending

Quality

—

Price

—

Fair value

—

Price / FV

—

The parent

Vivani Medical, Inc.VANI

Market cap

$90M

Moat

None

Quality

Price

$1.49

Fair value

—

Price / FV

—

Moat ratings, quality scores and fair value estimates are MoatScope research opinions and refresh with the data pipeline. Price / FV below 1.00× means the shares trade under our base-case estimate.

What is being separated

Cortigent develops brain-implant medical devices and neurostimulation systems intended to help patients recover critical body functions. Vivani Medical keeps its miniature, ultra-long-acting GLP-1 implants for weight management and type 2 diabetes. Both are small, pre-commercial companies.

Stated rationaleVivani says separating the two programs gives each management team a single focus and lets each company raise capital on its own merits.

The four questions

The four-question write-up for Cortigent, Inc. is pending. Terms, documents and both companies’ numbers above are live; the checklist is added once the information statement has been worked through.

Not investment advice. Terms are as stated in the latest filing; spin-off shares are often thinly covered and volatile in their first months.